Table 2 |
||||||
|
Incidence rate of clinical malaria and protective efficacy after 52 weeks of follow-up per treatment group and age category |
||||||
| <5 years |
5–10 years |
All |
||||
|
|
|
|
||||
| sIPT- |
sIPT + |
sIPT- |
sIPT + |
sIPT- |
sIPT + |
|
|
|
||||||
| Number of malaria episodes |
127 |
65 |
94 |
65 |
221 |
130 |
| Person-days (-years) of follow up |
17311 (47.6) |
16590(45.6) |
20799 (57.1) |
24025 (66.0) |
38110 (104.7) |
40615 (111.6) |
| Incidence rate malaria disease per 1000 person-days (-years) of follow up |
7.3 (2.67) |
3.9(1.43) |
4.5 (1.65) |
2.7 (0.98) |
5.8 (2.11) |
3.2 (1.16) |
| Unadjusted PE in % (95% CI) |
Reference group |
46.6 (28.0–60.4 |
Reference group |
40.1 (17.9–56.4) |
Reference group |
44.8 (31.5–55.6) |
| Age adjusted PE in % (95% CI) |
Reference group |
46.6 (28.0 – 60.4) |
Reference group |
35.9 (11.8–53.4) |
Reference group |
42.5 (28.6 – 53.8) |
|
|
||||||
|
sIPT - = control group sIPT + = treatment group PE = Protective efficacy |
||||||
|
Dicko et al. Malaria Journal 2008 7:123 doi:10.1186/1475-2875-7-123 |
||||||
